CEL-SCI’s shares dropped 38.19% after announcing a $10 million public offering priced below market value to fund its cancer immunotherapy development.
Why Is CEL-SCI Stock Crashing After-Hours?
Where Today's News Shapes Tomorrow
February 27, 2026
Headlines
